Northern Trust’s Procept Biorobotics PRCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PRCT
VPM
VCM
CC
PM
Northern Trust's PRCT Position: Q1 2026 in Review
Northern Trust reduced its Procept Biorobotics (PRCT) stake by 0.2% in Q1 2026, selling an estimated $30.6K and leaving 552,018 shares worth $13.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1899.
Northern Trust first reported a position in PRCT in Q4 2021 and has held it in 18 quarters since. The position peaked at $35.9M in Q4 2024. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.
- Northern Trust held 552,018 shares of Procept Biorobotics worth $13.8M as of Q1 2026.
- Northern Trust sold 1,085 Procept Biorobotics shares in Q1 2026, an estimated $30.6K.
- Procept Biorobotics made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #1899 holding.
- Northern Trust first reported a position in Procept Biorobotics in Q4 2021 and has held it in 18 quarters since.
- Northern Trust's Procept Biorobotics position peaked at $35.9M in Q4 2024.
- 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.